precision oncology market
DESCRIPTION
Precision Oncology MarketTRANSCRIPT
Precision Oncology Market To Reach USD 99.72 Billion By 2027
Market Summary
The advancement in healthcare is beneficial for patients, the pharmaceutical industry, and society.
Market Size – USD 49.98 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Improvement and advancement in cancer biology.
The global Precision Oncology market is forecast to reach USD 99.72 Billion by 2027, according to a new report by Reports and Data. Precision oncology categories, recent advances in cancer care have been closely associated with genomic medicine. Knowing the genetic mutations of unique tumors holds the promise of giving practitioners a higher capacity to command specific prescriptions to fight specific tumors types. Although, only a few tumors and tumor types have been correlated with specific genetic mutations. In some forms of breast cancer, doctors instantly have years of expertise in genomic analysis to determine the most appropriate methods for their patients.
Market Summary
Further key findings from the report suggest
• The Application is anticipated to reach USD 22.33 billion by 2027 and is expected to grow at a high rate over the forecast period.
• Demand for Precision oncology in defense is anticipated to witness moderate growth over the forecast period.
• The End-user segment dominated the market in 2019, with an estimated USD 99.72 billion.
• The global Precision Oncology market accounted for USD 49.98 billion in 2019 and is expected to grow at a CAGR of 9.9% from 2019 to 2027.
Avail the inside scoop of the Sample report @ https://www.reportsanddata.com/sample-enquiry-form/3353
Market Summary
Key players Companies considered and profiled in this market study, Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc. NeoGenomics, Novartis AG, Pfizer Inc., QIAGEN, Tepnel Pharma Services, Teva Pharmaceuticals Industries Ltd, among others.
Segmentation:For the purpose of this report, Reports and Data have segmented into the global Cathode Materials market on the basis of battery type, materials, end-use industries, and region:End-user Outlook (Revenue, USD Billion; 2017-2027)• Pharmaceuticals Companies• Biotechnology Companies• Diagnostic Companies• Healthcare Data Companies
Technology Type Outlook (Revenue, USD Million; 2017-2027)• Big data Analytics• Bioinformatics• Gene Sequencing• Drug Discovery• Companies Diagnostics
Market Summary
Application Outlook (Revenue, USD Billion; 2017-2027)• Consumable• Instruments• ServicesRegional Outlook (Volume, Kilo Tons; Revenue, USD Billion; 2016-2026)• North America• Europe• Asia Pacific• MEA• Latin America Buy Now: https://www.reportsanddata.com/checkout-form/3353
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision.
We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
About US
John WatsonHead of Business DevelopmentReports And Data | Web: www.reportsanddata.comDirect Line: +1-212-710-1370E-mail: [email protected]
Contact US